Mucosal Adjuvants

Mucosal Adjuvant is a substance that enhances the induction and modulation of immune responses at mucosal surfaces when co-administered with an antigen, distinguishing it from systemic adjuvants by its targeted activity within the mucosal immune system.

258

Publications

12K

Citations

1.3K

Authors

393

Institutions

Publications per year

2017–2026

35

Variants

Mucosal Adjuvant

Publications

258

Authors

1.3K

  1. RR
    Rino Rappuoli

    Novartis (Italy), Italy

    16 publications · 1.7K citations

    15

    h-index

  2. MP
    Mariagrazia Pizza

    Novartis (Italy), Italy

    10 publications · 1.1K citations

    10

    h-index

  3. NL
    Nils Lycke

    University of Gothenburg, Sweden

    10 publications · 728 citations

    10

    h-index

  4. CA
    Carlos A. Guzmán

    Helmholtz Centre for Infection Research, Germany

    8 publications · 438 citations

    8

    h-index

  5. GD
    Giuseppe Del Giudice

    Novartis (Italy), Italy

    8 publications · 784 citations

    8

    h-index

1–5 of 1.3K

Venues

  1. Vaccine

    42 publications · 1.7K citations

    27

    h-index

  2. Infection and Immunity

    IAI · 23 publications · 1.4K citations

    21

    h-index

  3. PLoS ONE

    17 publications · 785 citations

    15

    h-index

  4. The Journal of Immunology

    JI · 13 publications · 982 citations

    13

    h-index

  5. European Journal of Immunology

    EJI · 11 publications · 510 citations

    11

    h-index

1–5